CopyMark Law Group
4.9/5
Drawing for VIROFREE

USPTO serial 97105083

VIROFREE

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
COLLOPY, DIANE PATRICIA
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with VIROFREE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Trademark Monitoring
(312) 319-4460
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Start a new application
(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Michael T. Smith

Michael T. Smith BIRCH STEWART KOLASCH & BIRCH LLP2600 Park Tower Drive, Suite 600Vienna, VA 22180United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations containing antivirals for the treatment of virus infections; dietary fiber for treating constipation; food supplements, namely, anti-oxidants; fungal extracts sold as a component ingredient of nutritional supplements and vitamins; multi-vitamin preparations; natural herbal supplements; nutritional supplement meal replacement bars for boosting energy; nutritional supplements; vitamin and nutritional supplements; vitamin and mineral supplements; chemico-pharmaceutical preparations containing antivirals for the treatment of respiratory tract infections, flu, covid-19 and long covid; medicines made of traditional chinese medicinal herbs; fried medicinal herbs; biological preparations containing antivirals for medical purposes for the treatment of respiratory tract infection, flu, covid-19 and long covid; protein dietary supplements; plant extracts for pharmaceutical purposes; herbal extracts for medical purposes; bacterial preparations containing antivirals for medical and veterinary use; albuminous foodstuffs for medical purposes, namely, albumin dietary supplements, herbal dietary supplements and proteinic dietary supplements; nutraceutical preparations containing antivirals for therapeutic or medical purposes for the treatment of respiratory tract infections, flu, covid-19 and long covid; plant extract nutritional supplements; multi-vitamin nutritional supplementsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jul 6, 2026MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jul 6, 2026ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Apr 27, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 27, 2026EX5GSOU EXTENSION 5 GRANTED—
Apr 27, 2026AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Nov 3, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 2, 2025EXT5SOU EXTENSION 5 FILED—
May 14, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 14, 2025EX4GSOU EXTENSION 4 GRANTED—
May 13, 2025EXT4SOU EXTENSION 4 FILED—
May 13, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 5, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 5, 2024EX3GSOU EXTENSION 3 GRANTED—
Nov 5, 2024EXT3SOU EXTENSION 3 FILED—
Nov 5, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 23, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 22, 2024EX2GSOU EXTENSION 2 GRANTED—
May 22, 2024EXT2SOU EXTENSION 2 FILED—
May 22, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 12, 2024DOCKASSIGNED TO EXAMINER—
Oct 14, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 12, 2023EX1GSOU EXTENSION 1 GRANTED—
Oct 12, 2023EXT1SOU EXTENSION 1 FILED—
Oct 12, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 30, 2023NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Apr 4, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 4, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 15, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 2, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 2, 2023XAECEXAMINER'S AMENDMENT ENTERED—
Mar 2, 2023GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Mar 2, 2023GNEAEXAMINERS AMENDMENT E-MAILED—
Mar 2, 2023CNEAEXAMINERS AMENDMENT -WRITTEN—
Feb 10, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 9, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 9, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 17, 2022GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 17, 2022GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 17, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 11, 2022DOCKASSIGNED TO EXAMINER—
Nov 12, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 5, 2021NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance